Not so long ago, a new anorectic drug – Belviq has appeared on the shelves of US pharmacies. It was approved by the U.S. FDA in June 2012. The main difference of Belviq from other anorectics, such as Duromine, Adipex P and Phentermine is to use other active substance.
Active substance of Belviq is Lorcaserin hydrochloride.
- This substance suppresses the person’s appetite and promotes rapid saturation. Herewith, the person feels full of energy and his working capacity increases by several times.
The manufacturer of Belviq is a Swiss pharmaceutical company, Arena Pharmaceuticals GmbH. The drug comes in round blue tablets in the dose of 10 mg.
The tablets debossed with “A” on one side and “10” – on other side. Weight loss experts recommend using Belviq in the combination with physical loads and balanced diet.
Belviq is contraindicated to pregnant women and breastfeeding mothers.
- A lot of physicians believe weight loss during pregnancy can negatively affect the fetus development and the health state of the pregnant woman.
Although, there are no direct confirmations that active ingredient can pass into breast milk, yet physicians recommend to refrain from Belviq use during nursing.